These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28849039)

  • 1. Expression of microRNA‑222 in serum of patients with Alzheimer's disease.
    Zeng Q; Zou L; Qian L; Zhou F; Nie H; Yu S; Jiang J; Zhuang A; Wang C; Zhang H
    Mol Med Rep; 2017 Oct; 16(4):5575-5579. PubMed ID: 28849039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
    Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
    J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
    Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
    Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
    Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-125b as a biomarker of Alzheimer's disease.
    Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L
    J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA expression profiling in patients with multiple system atrophy.
    Kume K; Iwama H; Deguchi K; Ikeda K; Takata T; Kokudo Y; Kamada M; Fujikawa K; Hirose K; Masugata H; Touge T; Masaki T
    Mol Med Rep; 2018 Jan; 17(1):852-860. PubMed ID: 29115515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Blood MicroRNA Expression Profiles in Alzheimer's Disease: Screening, Validation, Association with Clinical Phenotype and Implications for Molecular Mechanism.
    Ren RJ; Zhang YF; Dammer EB; Zhou Y; Wang LL; Liu XH; Feng BL; Jiang GX; Chen SD; Wang G; Cheng Q
    Mol Neurobiol; 2016 Oct; 53(8):5772-81. PubMed ID: 26497032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
    Jia LH; Liu YN
    Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting Circulating MicroRNAs as Biomarkers in Alzheimer's Disease.
    Kenny A; Jimenez-Mateos EM; Calero M; Medina M; Engel T
    Methods Mol Biol; 2018; 1779():471-484. PubMed ID: 29886551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Alzheimer's Disease-related miRNA Based on Semi-clustering.
    Zhao T; Wang D; Hu Y; Zhang N; Zang T; Wang Y
    Curr Gene Ther; 2019; 19(4):216-223. PubMed ID: 31549953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome analysis reveals non-identical microRNA profiles between arterial and venous plasma.
    Xu W; Zhou Y; Xu G; Geng B; Cui Q
    Oncotarget; 2017 Apr; 8(17):28471-28480. PubMed ID: 28212530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.
    Geekiyanage H; Jicha GA; Nelson PT; Chan C
    Exp Neurol; 2012 Jun; 235(2):491-6. PubMed ID: 22155483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
    van Harten AC; Mulders J; Scheltens P; van der Flier WM; Oudejans CB
    J Alzheimers Dis; 2015; 47(1):243-52. PubMed ID: 26402772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
    Batistela MS; Josviak ND; Sulzbach CD; de Souza RL
    Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating Alzheimer's disease micro RNAs using next-generation sequencing.
    Keller A; Backes C; Haas J; Leidinger P; Maetzler W; Deuschle C; Berg D; Ruschil C; Galata V; Ruprecht K; Stähler C; Würstle M; Sickert D; Gogol M; Meder B; Meese E
    Alzheimers Dement; 2016 May; 12(5):565-76. PubMed ID: 26806387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic biomarkers for Alzheimer's disease in human-derived platelets.
    Min JW; Lee J; Mun HJ; Kim DH; Park BG; Yoon B; Ryu JH; Cho HJ
    Genes Genomics; 2020 Dec; 42(12):1467-1475. PubMed ID: 33180258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Blood Levels of MicroRNA-9 Are Decreased in Patients With Late-Onset Alzheimer Disease.
    Souza VC; Morais GS; Henriques AD; Machado-Silva W; Perez DIV; Brito CJ; Camargos EF; Moraes CF; Nóbrega OT
    Am J Alzheimers Dis Other Demen; 2020; 35():1533317520911573. PubMed ID: 32301334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
    Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
    J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.